Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.021 | 0.6991 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0116 | 0.2879 | 0.4118 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0057 | 0.0285 | 0.0139 |
Brugia malayi | TAR-binding protein | 0.021 | 0.6991 | 0.6945 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0112 | 0.271 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0244 | 0.8456 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.017 | 0.5232 | 0.516 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0149 | 0.0213 |
Brugia malayi | RNA binding protein | 0.021 | 0.6991 | 0.6945 |
Brugia malayi | MH2 domain containing protein | 0.014 | 0.391 | 0.3818 |
Leishmania major | hypothetical protein, conserved | 0.0112 | 0.271 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0149 | 0.0213 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.017 | 0.5232 | 0.516 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.0149 | 0.0149 |
Schistosoma mansoni | survival motor neuron protein | 0.0057 | 0.0285 | 0.0408 |
Schistosoma mansoni | tar DNA-binding protein | 0.021 | 0.6991 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.0149 | 0.0149 |
Brugia malayi | RNA recognition motif domain containing protein | 0.021 | 0.6991 | 0.6945 |
Echinococcus multilocularis | GPCR, family 2 | 0.0054 | 0.0149 | 0.0149 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0112 | 0.271 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0149 | 0.0213 |
Loa Loa (eye worm) | hypothetical protein | 0.017 | 0.5232 | 0.516 |
Echinococcus granulosus | tar DNA binding protein | 0.021 | 0.6991 | 0.6991 |
Loa Loa (eye worm) | hypothetical protein | 0.0279 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.021 | 0.6991 | 0.6945 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.014 | 0.391 | 0.3818 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0279 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0116 | 0.2879 | 0.2772 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.271 | 0.26 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0112 | 0.271 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.021 | 0.6991 | 0.6945 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0149 | 0.0213 |
Onchocerca volvulus | 0.0057 | 0.0285 | 0.5 | |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.0149 | 0.0149 |
Brugia malayi | hypothetical protein | 0.0112 | 0.271 | 0.26 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0112 | 0.271 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0054 | 0.0149 | 0.0149 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0112 | 0.271 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.021 | 0.6991 | 0.6945 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.2879 | 0.2772 |
Schistosoma mansoni | tar DNA-binding protein | 0.021 | 0.6991 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 0.0285 | 0.0408 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.017 | 0.5232 | 0.516 |
Schistosoma mansoni | tar DNA-binding protein | 0.021 | 0.6991 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.0149 | 0.0149 |
Schistosoma mansoni | tar DNA-binding protein | 0.021 | 0.6991 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0112 | 0.271 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.021 | 0.6991 | 0.6991 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0279 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.014 | 0.391 | 0.3818 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0112 | 0.271 | 0.5 |
Brugia malayi | hypothetical protein | 0.0072 | 0.0968 | 0.0832 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.